November 2023
1. BAILEY S, Ferraresso M, Alonso-Crisostomo L, Ward D, et al
   Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.
   Br J Cancer. 2023 Nov 2. doi: 10.1038/s41416-023-02479.
   

   >> Share

   
   October 2023
2. BAILEY S, Ferraresso M, Alonso-Crisostomo L, Ward D, et al
   Targeting oncogenic microRNAs from the miR-371~373 and miR-302/267 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.
   Br J Cancer. 2023 Oct 3. doi: 10.1038/s41416-023-02453.
   

   >> Share

   
   September 2023
3. LAURITSEN J, Sauve N, Tryakin A, Jiang DM, et al
   Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
   Br J Cancer. 2023 Sep 30. doi: 10.1038/s41416-023-02443.
   

   >> Share

   
   
4. BREMMER F, Pongratanakul P, Skowron M, Che Y, et al
   Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets.
   Br J Cancer. 2023 Sep 19. doi: 10.1038/s41416-023-02425.
   

   >> Share

   
   April 2023
5. JANSSON AK, Soderling J, Reutfors J, Thor A, et al
   Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders.
   Br J Cancer. 2023 Apr 24. doi: 10.1038/s41416-023-02260.
   

   >> Share

   
   
6. FUNKE K, Einsfelder U, Hansen A, Arevalo L, et al
   Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours.
   Br J Cancer. 2023 Apr 6. doi: 10.1038/s41416-023-02247.
   

   >> Share

   
   October 2022
7. BUTLER EN, Zhou CK, Curry M, McMenamin U, et al
   Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
   Br J Cancer. 2022 Oct 28. pii: 10.1038/s41416-022-02019.
   

   >> Share

   
   
8. FONSECA A, Lobo J, Hazard FK, Gell J, et al
   Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.
   Br J Cancer. 2022 Oct 13. pii: 10.1038/s41416-022-02000.
   

   >> Share

   
   September 2022
9. YKEMA BLM, Breekveldt ECH, Carvalho B, van Wezel T, et al
   Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors.
   Br J Cancer. 2022 Sep 10. pii: 10.1038/s41416-022-01972.
   

   >> Share

   
   April 2022
10. ANDREASSEN CH, Lorenzen M, Nielsen JE, Kafai Yahyavi S, et al
    RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma.
    Br J Cancer. 2022 Apr 13. pii: 10.1038/s41416-022-01810.
    

    >> Share

    
    
11. CIGAN SS, Meredith JJ, Kelley AC, Yang T, et al
    Predicted leukocyte telomere length and risk of germ cell tumours.
    Br J Cancer. 2022 Apr 2. pii: 10.1038/s41416-022-01798.
    

    >> Share

    
    January 2022
12. NESTLER T, Dalvi P, Haidl F, Wittersheim M, et al
    Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours.
    Br J Cancer. 2022 Jan 12. pii: 10.1038/s41416-021-01621.
    

    >> Share

    
    December 2021
13. FANKHAUSER CD, Christiansen AJ, Rothermundt C, Cathomas R, et al
    Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
    Br J Cancer. 2021 Dec 15. pii: 10.1038/s41416-021-01643.
    

    >> Share

    
    October 2021
14. NICHOLSON S, Tovey H, Elliott T, Burnett SM, et al
    VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01574.
    

    >> Share

    
    August 2021
15. MULLEE A, Dimou N, Allen N, O'Mara T, et al
    Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses.
    Br J Cancer. 2021 Aug 6. pii: 10.1038/s41416-021-01518.
    

    >> Share

    
    September 2020
16. SHAMASH J, Ansell W, Alifrangis C, Thomas B, et al
    The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG).
    Br J Cancer. 2020 Sep 29. pii: 10.1038/s41416-020-01075.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share